Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 multiple ascending dose study of valemetostat tosylate in lymphoma
jRCT2080223118Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of valemetostat in non-Hodgkin lymphoma (NHL), sponsored by Daiichi Sankyo Co., Ltd. Started Feb 2016; status: completed.
02
Drugs
valemetostat
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on jRCT2080223118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223118.